Insulin, metformin do not reduce inflammatory biomarkers for diabetes patients
Tuesday, September 15, 2009 - 15:56
in Health & Medicine
CHICAGO -- In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study in the September 16 issue of JAMA.